Evidence map›Paper›PMID 27861592›Full record

ArticlePloS one2016

Hyperoxia-Induced Proliferative Retinopathy: Early Interruption of Retinal Vascular Development with Severe and Irreversible Neurovascular Disruption.

Michelle Lajko, Herminio J Cardona, Joann M Taylor, Ronil S Shah, Kathryn N Farrow, Amani A Fawzi

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Pediatric retinal vascular disorders: From translational sciences to clinical practice.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michelle LajkoDepartment of Ophthalmology, Feinberg School of Medicine at Northwestern University, Chicago, Illinois, United States.
Herminio J CardonaDepartment of Pediatrics, Feinberg School of Medicine at Northwestern University, Chicago, Illinois, United States.
Joann M TaylorDepartment of Pediatrics, Feinberg School of Medicine at Northwestern University, Chicago, Illinois, United States.
Ronil S ShahDepartment of Ophthalmology, Feinberg School of Medicine at Northwestern University, Chicago, Illinois, United States.
Kathryn N FarrowDepartment of Pediatrics, Feinberg School of Medicine at Northwestern University, Chicago, Illinois, United States.
Amani A FawziDepartment of Ophthalmology, Feinberg School of Medicine at Northwestern University, Chicago, Illinois, United States.
Northwestern University · US

Funding

Tumor Environment and Metastasis (TEAM) Research ProgramP30CA060553 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI LEONIDAS C. PLATANIAS · 1993 to 2026
$153.9M
Redox Regulation of Vascular cGMP Signaling in Neonatal LungsR01HL109478 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SCHUMACKER, PAUL T · 2011 to 2020
$4.2M
Manipulating cGMP Pathway to Impact Vascular Development in Neonatal BPD and ROPR21HD077336 · NICHD · NORTHWESTERN UNIVERSITY AT CHICAGO · PI FARROW, KATHRYN N, FAWZI, AMANI A · 2014 to 2015
$431k
NCI NIH HHS P30 CA060553NHLBI NIH HHS R01 HL109478NICHD NIH HHS R21 HD077336
6 · The paper itself

Abstract

Bronchopulmonary dysplasia (BPD) is a major cause of neonatal morbidity in premature infants, occurring as a result of arrested lung development combined with multiple postnatal insults. Infants with BPD exposed to supplemental oxygen are at risk of retinopathy of prematurity as well. Thus, we studied the effects of hyperoxia on the retinal vasculature in a murine model of BPD. The retinal phenotype of this model, which we termed hyperoxia-induced proliferative retinopathy (HIPR), shows severe disruption of retinal vasculature and loss of vascular patterning, disorganized intra-retinal angiogenesis, inflammation and retinal detachment. Neonatal mice were subjected to 75% oxygen exposure from postnatal day (P)0 to P14 to model BPD, then allowed to recover in room air for 1 (P15), 7 (P21), or 14 days (P28). We quantified retinal thickness, protein levels of HIF-1α, NOX2, and VEGF, and examined the cellular locations of these proteins by immunohistochemistry. We examined the retinal blood vessel integrity and inflammatory markers, including macrophages (F4/80) and lymphocytes (CD45R). Compared to controls, normal retinal vascular development was severely disrupted and replaced by a disorganized sheet of intra-retinal angiogenesis in the HIPR mice. At all time-points, HIPR showed persistent hyaloidal vasculature and a significantly thinner central retina compared to controls. HIF-1α protein levels were increased at P15, while VEGF levels continued to increase until P21. Intra-retinal fibrinogen was observed at P21 followed by sub-retinal deposition in at P28. Inflammatory lymphocytes and macrophages were observed at P21 and P28, respectively. This model presents a severe phenotype of disrupted retinal vascular development, intra-retinal angiogenesis inflammation and retinal detachment.

Indexed as

AnimalsCollagenDisease Models, AnimalGene ExpressionHumansHyperoxiaHypoxia-Inducible Factor 1, alpha SubunitImmunohistochemistryMembrane GlycoproteinsMiceNADPH Oxidase 2NADPH OxidasesOxygenRetinaRetinal Ganglion CellsRetinal NeovascularizationCollagenCybb protein, mouseHypoxia-Inducible Factor 1, alpha SubunitMembrane GlycoproteinsNADPH Oxidase 2NADPH OxidasesOxygenVascular Endothelial Growth Factor AVascular Endothelial Growth Factor Receptor-2

Identifiers

PMID27861592
PMCPMC5115836
OpenAlexW2554088287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.